Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Xth Eurasian Hematology-Oncology Congress
M

Therapy for Recurrent GIST following Adjuvant Treatment: Imatinib Re-Induction is Effective in Most Patients, Surgery is Option only in Oligometastatic Disease, Recurrence After Adjuvant Treatment Means Metastatic Setting

By Xth Eurasian Hematology-Oncology Congress FEATURING Maxim Nikulin
By Xth Eurasian Hematology-Oncology Congress FEATURING Maxim Nikulin
0 views
January 8, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Sarcoma
20:54
Xth Eurasian Hematology-Oncology Congress

Molecular and Morphological Diagnosis in Bone and Soft Tissue Tumors

Feat. M. Gambarotti
17:29
Xth Eurasian Hematology-Oncology Congress

Small Cell Sarcomas: Definition, Classification, Histology, and How …

Feat. K. Ates
26:55
Xth Eurasian Hematology-Oncology Congress

Can We Ever Have a Specific Treatment for All 50 Subtypes of Soft Ti…

Feat. C. Avsar
16:45
Xth Eurasian Hematology-Oncology Congress

Therapy for Recurrent GIST following Adjuvant Treatment: Imatinib Re…

Feat. M. Nikulin